Targeting the CD47-SIRPA Axis in Oncology Analytical Tool 2022: 70 Companies and Partners Developing 81 CD47-SIRPA Axis Targeting Drugs 76 in Active Development Across 28 Different Targets

/PRNewswire/ -- The "Targeting the CD47-SIRPA Axis in Oncology: Analytical Tool" report has been added to ResearchAndMarkets.com's offering. Targeting the...

Related Keywords

Dublin ,Ireland ,Laura Wood ,E St Office Hours Call ,Office Hours Call ,Clinical Trial Development ,Biomarker Companion Diagnostic Development ,Business Development Licensing ,Conference Coverage ,Companion Diagnostic Development ,Therapy Choices ,Analytical Tool ,Business Development ,How To Training Videos ,Analytical Tools ,Free Call ,Hours Call ,Research And Markets ,Medical Pharmaceuticals ,Publishing Amp Information Services ,Health Care Amp Hospitals ,Pharmaceuticals ,Market Research Reports ,